These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7988299)

  • 1. Arginine-induced insulin release in glucokinase-deficient subjects.
    Pueyo ME; Clement K; Vaxillaire M; Passa P; Froguel P; Robert JJ; Velho G
    Diabetes Care; 1994 Sep; 17(9):1015-21. PubMed ID: 7988299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.
    Byrne MM; Sturis J; Clément K; Vionnet N; Pueyo ME; Stoffel M; Takeda J; Passa P; Cohen D; Bell GI
    J Clin Invest; 1994 Mar; 93(3):1120-30. PubMed ID: 8132752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1alpha (maturity-onset diabetes of the young-3) mutations.
    Vaxillaire M; Pueyo ME; Clément K; Fiet J; Timsit J; Philippe J; Robert JJ; Tappy L; Froguel P; Velho G
    Eur J Endocrinol; 1999 Dec; 141(6):609-18. PubMed ID: 10601964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
    Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Jos J; Boitard C; Assan R; Robert JJ
    Diabetes Care; 1995 Nov; 18(11):1487-90. PubMed ID: 8722075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin responses to intravenous glucose, intravenous arginine and a hyperglycaemic clamp in ICA-positive subjects with different degrees of glucose tolerance.
    Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Gautier D; Jos J; Boitard C; Robert JJ
    Diabetes Metab; 1997 Feb; 23(1):43-50. PubMed ID: 9059765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion.
    Cretti A; Lehtovirta M; Bonora E; Brunato B; Zenti MG; Tosi F; Caputo M; Caruso B; Groop LC; Muggeo M; Bonadonna RC
    Eur J Clin Invest; 2001 May; 31(5):405-16. PubMed ID: 11380592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response characteristics for arginine-stimulated insulin secretion in man and influence of hyperglycemia.
    van Haeften TW; Voetberg GA; Gerich JE; van der Veen EA
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1059-64. PubMed ID: 2677037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with a glucokinase Glu256Lys mutation.
    Wajngot A; Alvarsson M; Glaser A; Efendic S; Luthman H; Grill V
    Diabetes; 1994 Dec; 43(12):1402-6. PubMed ID: 7958490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
    Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
    Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of an oral mixed meal plus arginine and intravenous glucose, GLP-1 plus arginine to unmask residual islet function in longstanding type 1 diabetes.
    Uitbeijerse BS; Nijhoff MF; de Koning EJP
    Am J Physiol Endocrinol Metab; 2024 May; 326(5):E673-E680. PubMed ID: 38446636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
    Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
    Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.
    van Haeften TW; Dubbeldam S; Zonderland ML; Erkelens DW
    Diabetes Care; 1998 Feb; 21(2):278-82. PubMed ID: 9539996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.
    Fritsche A; Stefan N; Hardt E; Schützenauer S; Häring H; Stumvoll M
    Eur J Clin Invest; 2000 May; 30(5):411-8. PubMed ID: 10809901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet amyloid polypeptide response to maximal hyperglycemia and arginine is altered in impaired glucose tolerance and type 2 diabetes mellitus.
    Guardado-Mendoza R; Chávez AO; Jiménez-Ceja LM; Hansis-Diarte A; DeFronzo RA; Folli F; Tripathy D
    Acta Diabetol; 2017 Jan; 54(1):53-61. PubMed ID: 27624579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus.
    Shankar RR; Zhu JS; Baron AD
    Metabolism; 1998 May; 47(5):573-7. PubMed ID: 9591749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acute hyperglycemia on insulin secretion in humans.
    Toschi E; Camastra S; Sironi AM; Masoni A; Gastaldelli A; Mari A; Ferrannini E; Natali A
    Diabetes; 2002 Feb; 51 Suppl 1():S130-3. PubMed ID: 11815471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats.
    Balkan B; Dunning BE
    Diabetes; 1994 Oct; 43(10):1173-9. PubMed ID: 7926284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.
    Herman WH; Fajans SS; Smith MJ; Polonsky KS; Bell GI; Halter JB
    Diabetes; 1997 Nov; 46(11):1749-54. PubMed ID: 9356021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.